Novo Nordisk Investigational Site

Alkmaar 1815 JD

0 studies enrolling now · 1 studies all time

What they study most

Hepatobiliary Disorders, Non-alcoholic Steatohepatitis

Studies at this site

• Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. — Completed